Literature DB >> 15996239

A comparison of populations served by kidney paired donation and list paired donation.

Sommer E Gentry1, Dorry L Segev, Robert A Montgomery.   

Abstract

Options for utilizing live donor kidneys from those who are blood type incompatible or crossmatch positive with their intended recipients include kidney paired donation (KPD), list paired donation (LPD) and desensitization. KPD provides live donor kidneys for both recipients but requires a match to another incompatible pair, while LPD utilizes the deceased donor pool but is restricted by ethical and logistic concerns. We simulated patients and their potential donors to determine which recipients could receive a kidney through KPD and LPD. With smaller populations (100 pairs or fewer), more kidneys were matched through LPD, although the greatest benefit was derived from a combination of LPD and KPD. With increasing population sizes, more patients were matched through KPD, including almost all patients who would have been eligible for LPD. At population sizes predicted to be achieved by a national paired donation system, the role of LPD became minimal, with only 3.9% of pairs unmatched through KPD eligible for LPD. Considerable overlap was seen between the pairs unmatchable by KPD and those ineligible for LPD, namely less-demanded donors and hard-to-match recipients. For this population, the best option may be desensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996239     DOI: 10.1111/j.1600-6143.2005.00964.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Willingness of the United States general public to participate in kidney paired donation.

Authors:  Dorry L Segev; Neil R Powe; Misty U Troll; Nae-Yuh Wang; Robert A Montgomery; L Ebony Boulware
Journal:  Clin Transplant       Date:  2012-03-08       Impact factor: 2.863

2.  [Questionnaire on crossover renal transplantations in Germany].

Authors:  A Hamza; H Loertzer; A Wicht; O Rettkowski; E Koch; P Fornara
Journal:  Urologe A       Date:  2006-01       Impact factor: 0.639

Review 3.  Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy.

Authors:  Maria Sassi; Umberto Maggiore; Carlo Buzio; Massimo Franchini
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

4.  A Risk Index for Living Donor Kidney Transplantation.

Authors:  A B Massie; J Leanza; L M Fahmy; E K H Chow; N M Desai; X Luo; E A King; M G Bowring; D L Segev
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086

Review 5.  Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention.

Authors:  Amy D Waterman; James R Rodrigue; Tanjala S Purnell; Keren Ladin; L Ebony Boulware
Journal:  Semin Nephrol       Date:  2010-01       Impact factor: 5.299

6.  Outcomes of ABO-incompatible kidney transplantation in the United States.

Authors:  John R Montgomery; Jonathan C Berger; Daniel S Warren; Nathan T James; Robert A Montgomery; Dorry L Segev
Journal:  Transplantation       Date:  2012-03-27       Impact factor: 4.939

7.  Algorithms and Time Complexity of the Request-Service Problem.

Authors:  Chunmei Liu; Legand Burge; Ajoni Blake
Journal:  J Comb Optim       Date:  2010-08-01       Impact factor: 1.195

Review 8.  Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.

Authors:  Daniel S Warren; Robert A Montgomery
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

9.  Desensitization combined with paired exchange leads to successful transplantation in highly sensitized kidney transplant recipients: strategy and report of five cases.

Authors:  J M Yabu; M J Pando; S Busque; M L Melcher
Journal:  Transplant Proc       Date:  2013 Jan-Feb       Impact factor: 1.066

10.  Center-level utilization of kidney paired donation.

Authors:  A B Massie; S E Gentry; R A Montgomery; A A Bingaman; D L Segev
Journal:  Am J Transplant       Date:  2013-03-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.